Valuations - Strategic & Financial Advisors - SLM … · Valuations 2017 Jan 2017 ASX listed...
Transcript of Valuations - Strategic & Financial Advisors - SLM … · Valuations 2017 Jan 2017 ASX listed...
Valuations
2017
Jan 2017 ASX listed biotech Valuation of performance rights
Feb 2017 ASX listed 3D printing Valuation of performance rights
Feb 2017 ASX listed prawn farming venture Valuation of project for purposes of native title compensation
Mar 2017 ASX listed water treatment
solutions provider
Independent valuation for acquisition
Mar 2017 ASX listed financing company
Valuation of earn out shares
Mar 2017 Private ophthalmology business Valuation of business for sale
Apr 2017 ASX listed industrial company Independent valuation of the rights to commercialise certain Intellectual Property
April 2017 Offshore supermarket chain Valuation for acquisition
May 2017 Private business providing services
to the not for profit sector
Independent valuation for restructuring
May 2017 Waste disposal project Valuation for purposes of native title compensation
May 2017 ASX listed exploration company Valuation for options and performance rights
May 2017 ASX listed police check and
security verification company
Impairment and options valuation
May 2017 ASX listed cosmetics company Valuation of performance rights
May 2017 ASX listed forestry project IER
May 2017 ASX listed biotech Impairment testing
June 2017 Private, matrimonial Expert valuation, ASX listed holdings
June 2017 Car parking manager Expert valuation for litigation purposes
June 2017 Privately owned
telecommunications company
Valuation for the purposes of a group restructure and sale
June 2017 ASX listed biotech Valuation for impairment testing
June 2017 Iron ore project Valuation for native title compensation
July 2017 ASX listed security and risk
management company
Valuation of options
July 2017 Timber Creek Expert valuation for native title compensation
Aug 2017 Private individual Expert financial report for purposes of family court litigation – valuation of significant
holdings in ASX listed companies
Aug 2017 Private ophthalmology company Valuation for sale
Sept 2017 Private fashion chain Valuation for acquisition
Sept 2016 Private gold exploration company Valuation of options for the purposes of year end accounts and prospective IPO
Sept 2017 ASX listed metals and mining
company
Valuation of options
Sept 2017 ASX listed biotech Valuation of options
Oct 2017 ASX listed oil and gas company Valuation of performance rights
Oct 2017 ASX listed explorer Valuation of options
Oct 2017 ASX listed paper and packaging
company
Valuation of performance rights
Oct 2017 ASX listed mining company Valuation of performance rights
Nov 2017 Brand IP, private milk business Valuation for purposes of restructure and sale
Nov 2017 ASX listed oil and gas company Valuation of options
2016
Jan 2016 ASX listed biotech Valuation of options for executive director
Feb 2016 ASX listed financial services
company
Valuation of business
Feb 2016 ASX listed technology company Valuation of director options
Mar 2016 Private technology company
Independent valuation
Mar 2016 ASX listed oil and gas company
Valuation of options for executive director
Apr 2016 ASX listed exploration and
development company
Valuation of options for directors following a takeover
Apr 2016 ASX listed industrial company Valuation of divisions for purposes of evaluating bids
Apr 2016 ASX listed exploration company Independent valuation for the purposes of s611 item 7
Apr 2016 Oceania Capital Partners Limited Independent valuation for the purposes of s611 item 7, following the share buyback
transaction announced by its parent HCI
Apr 2016 Private arborist company Valuation for the purposes of admitting a new shareholder
May 2016 ASX listed personal care company Valuations for the purposes of AASB 3
May 2016 Private recruitment firm in the
health care space
Valuation for the purposes of an acquisition
May 2016 ASX listed technology rentals
company
Valuation for the purposes of AASB 3
May 2016 ASX listed auto classified business Valuation of performance rights
June 2016 ASX mining services company Valuation of performance rights
June 2016 Privately owned marketing
company
Valuation for the purposes of a group restructure
June 2016 Southern Gold Limited Valuation for the purposes of Listing Rule 7.1A.3
July 2016` Law firm Valuation for the purposes of acquiring a partner’s interests
July 2016 Private 3PL logistics company Valuation for the purposes of acquiring a shareholder’s interests
Aug 2016 Private individual Expert financial report for purposes of family court litigation – valuation of significant
holdings in ASX listed companies
Aug 2016 Private company Expert financial report for purposes of commercial litigation – valuation of brand
Sept 2016 Private gold exploration company Valuation of options for the purposes of year end accounts and prospective IPO
Sept 2016 ASX listed biotech Valuation pursuant to s611 item 7, for change of control transaction
Sept 2016 ASX listed biotech Valuation of options for Executive Chairman; reward benchmarking
Oct 2016 ASX listed resources company Valuation of options for directors and senior management
Oct 2016 ASX listed medical devices
company
Independent Expert Report, for purposes of a Section 611 item 7 transaction
Oct 2016 ASX listed pharmaceutical company Valuation of options for Chief Executive
Nov 2016 Private packaging business Valuation for purposes of capital raising
Nov 2016 ASX listed resources company Valuation of options and performance rights
Nov 2016 ASX listed identity verification
company
Valuation of options and performance rights
2015
Jan 2015 ASX listed oil and gas explorer Valuation of options for executive director
Feb 2015 ASX listed mining exploration
company
Valuation of performance rights for executive director
Feb 2015 Private medical clinic Independent valuation
Feb 2015 ASX listed biotech Valuation of options for executive director
Feb 2015 Law firm Independent valuation for partner dispute
Mar 2015 ASX listed mining company Valuation of options for senior executives
Apr 2015 Private hotel developer Financial model
Apr 2015 Privately owned community assets
owner and operator
Financial model
Apr 2015 Australian Natural Proteins Limited Independent valuation for the purposes of seeking shareholder support to an
acquisition
May 2015 ASX listed mining company Valuation of options for director
May 2015 Privately owned construction
company
Valuation of shares for the purposes of a share sale transaction
May 2015 ASX listed mining company Valuation of options for key executive
June 2015 Jacana Minerals Limited Independent valuation for the purposes of an Independent Expert Report on the
proposed merger with Strandline Resources Limited
June 2015 ASX listed environmental
engineering and services company
Valuation of options for senior executives
June 2015 Private hotel development and
operating trust
Financial model
July 2015 ASX listed payments company Valuation of executive options and performance rights
July 2015 ASX listed gold explorer and
producer
Valuation of executive performance rights
July 2015 ASX listed gold explorer, developer
and producer
Valuation of executive options and performance rights
July 2015 ASX listed biopharmaceutical
company
Valuation of executive options
Aug 2015 Victorian Government business
asset
Valuation for strategic planning purposes
Aug 2015 Private water treatment company
preparing for back door listing
Valuation of executive options
Aug 2015 ASX listed online classified
business
Valuation of executive performance rights
Aug 2015 Public unlisted trading exchange
preparing for back door listing
Report on valuation methodology for restricted employee share issue
Sept 2015 ASX listed biotech
Valuation of performance rights
Sept 2015 Private company with an online
booking system
Valuation of share issue
Sept 2015 ASX listed environmental
engineering and services company
Valuation of options and performance rights to be issued to directors and senior
executives
Oct 2015 ASX listed medical device company
Valuation of IP
Oct 2015 ASX listed payments technology
company
Valuation of performance rights and options
Dec 2015 ASX listed software development
company
Valuation of options for executive and non-executive directors
2014
Jan 2014 Privately owned medical device
company
Valuation for purposes of a capital raising
Mar 2014 Privately owned fund manager
Valuation for purposes of share sales
Mar 2014 Casino gaming business
Valuation and financial modelling for proposed capital raising
May 2014 ASX listed environmental services
company
Valuation of executive options
May 2014 ASX listed satellite company
Valuation of performance rights for senior executive
Jun 2014 Mid cap ASX listed resources
company
Valuation of assets for the purposes of the directors expressing a view on a
proposed corporate transaction
Jun 2014 Unlisted public biotech company
Valuation of director and executive options for accounting purposes
Jul 2014 Mid cap ASX listed resources
company
Valuation of director options
Aug 2014 ASX listed biotech
Valuation of shares for purposes of takeover response strategy
Aug 2014 Private Registered Training
Organisation
Valuation of shares for purposes of sale
Aug 2014 Private Education Provider
Valuation of business for purposes of sale
Sept 2014 ASX listed technology company Independent valuation report for the board, for the purposes of a significant
restructure to be put to shareholders
Sept 2014 ASX listed biotech
Valuation of IP for purposes of impairment testing
Oct 2014 ASX listed biotech
Valuation of performance rights for Directors, for shareholder approval
Oct 2014 ASX listed oil and gas company
Valuation of performance rights for directors, for shareholder approval
2013
Feb 2013 Early stage medical device
company
Valuation for the purposes of a share incentive award
Apr 2013 Immune System Therapeutics Ltd Valuation of director share options
Apr 2013 Australian Natural Proteins Limited Independent Expert Report for section 611 item 7 transaction
Apr 2013 Argo Exploration Limited Valuation of performance rights to be granted to the Directors subject to
shareholder approval
May 2013 Immune System Therapeutics
Limited
Independent Expert Report for section 611 item 7 transaction
Aug 2013 ASX listed biotech
Valuation of subsidiary company shares for related party transaction
Sep 2013 Cellmid Limited
Valuation of Advangen Inc. for purposes of ASX Listing Rule 7.1A.3
Sep 2013 Newsat Limited Valuation of directors\' performance rights and options for purposes of a
shareholder meeting
Oct 2013 HuaYi Resources Limited
Valuation of director and broker options for a new IPO on ASX
Dec 2013 Invigor Group Limited
Independent Expert Report for section 611 item 7 transactions
Dec 2013 ASX listed environmental services
company
Valuation of CEO options for accounting purposes
Dec 2013 Asset management software
company
Valuation of shares for purposes of a share incentive award
2012
Dec 2012 Private pre revenue technology
company
Valuation for purposes of strategic investment
Aug 2012 ASX listed healthcare company
Valuation of consideration options
Aug 2012 ASX listed base metals and gold
exploration and development
company
Valuation of director options for purposes of seeking shareholder approval
Jul 2012 ASX listed graphite explorer and
developer
Valuation of remuneration options for financial reporting purposes
Jul 2012 Private consumer network business Valuation for purposes of issuing executive options
Jul 2012 ASX listed oil and gas exploration
and production company
Valuation of director options for financial reporting purposes
Jul 2012 Public unlisted algae based
industrial waste remediation
company
Fnancial modelling of project activities
Jul 2012 ASX listed environmental products
and services company
Valuation of remuneration options for financial reporting purposes
Jul 2012 ASX listed communications
company
Valuation of executive performance rights
Jun 2012 ASX listed healthcare company
Valuation of healthcare technologies for the purposes of impairment testing
May 2012 Public unlisted biotechnology
company
Valuation of director and executive options for financial reporting purposes
May 2012 ASX listed resources company
Independent Expert Report for strategic alliance transaction
May 2012 High growth private logistics
company
3-way forecast financial model for funding purposes
May 2012 Private greeting card business
Valuation for sale process
May 2012 Private engineering consultancy
business
Valuation for matrimonial settlement
Mar 2012 Private retail group with diverse
interests
3-way forecast financial model for finance application
Mar 2012 ASX listed Anittel Limited
Independent Expert Report for section 611(7) transaction
Mar 2012 ASX listed healthcare company
Valuation of early stage technologies for the purposes of impairment testing
Mar 2012 NSX listed exploration company
Valuation of director and executive options for financial reporting purposes
Feb 2012 ASX listed oil and gas exploration
company
Valuation of director and executive options for financial reporting purposes
Feb 2012 Start up online technology company Financial modelling for scenario analysis
Feb 2012 Private engineering consultancy
Independent valuation for purposes of possible sale transaction
Jan 2012 ASX listed exploration company
Valuation of director and executive options for financial reporting purposes
Jan 2012 ASX listed oil and gas exploration
company
Valuation of director and executive options and consideration options for financial
reporting purposes
Jan 2012 Privately owned precious metal
trading company
Independent valuation for purposes of possible sale transaction
Jan 2012 National supermarket chain
Independent review of financial model for strategic review purposes
2011
Dec 2011 ASX listed mining company
Valuation of director and executive options for financial reporting purposes
Dec 2011 Regional grocery clearance chain Independent valuation
Nov 2011 Manufacturer and distributer of
carbon products
Independent valuation for shareholder exit
Oct 2011 ASX listed Viento Group Limited
Independent Expert Report for section 611 (7) transaction
Oct 2011 Private algae company
Financial modelling updates
Jul - Sept 2011 ASX listed CMA Limited
Financial modelling for purposes of significant recapitalisation